Maia Hansen serves as Senior Vice President - Operations, Supply Chain of the Company. Ms. Hansen has extensive operations and supply chain experience in the pharmaceutical, medical device and consumer health sectors. Prior to joining Athersys, Ms. Hansen was a Senior Partner at McKinsey & Company, a global management consulting firm. She worked with clients around the world to develop and optimize end-to-end operations and global supply chains. Her work included the development of operations and supply chain strategy, capability building, manufacturing optimization, go-to-market effectiveness, and digital and analytics. In addition, she has worked with clients to connect operations with corporate strategy and product development. These projects included the development and execution of a manufacturing production system across a large, global network for a leading pharmaceutical company. Her work also enabled a health care company to improve collaboration between its product development team and outside suppliers to improve consumer experience and increase both productivity and margins. She was a leader within McKinsey's Operations practice and led the operations transformation and capability building service line to ensure impact across large-scale operations. In addition, Ms. Hansen served as the Managing Partner of McKinsey's Cleveland office.
Maia Hansen is 51, she's been the Senior Vice President - Operations a Supply Chain of Athersys Inc since 2020. There are 12 older and 2 younger executives at Athersys Inc. The oldest executive at Athersys Inc is Lorin Randall, 76, who is the Independent Director.
Maia's mailing address filed with the SEC is 3201, Carnegie Avenue, Midtown, Cleveland, Cuyahoga County, Ohio, 44115, United States.
Over the last 17 years, insiders at Athersys Inc have traded over $3,715,462 worth of Athersys Inc stock and bought 2,242,389 units worth $3,620,264 . The most active insiders traders include Advisors Llc Orbi Med Capit..., Michael B Sheffery a Jordan Davis. On average, Athersys Inc executives and independent directors trade stock every 43 days with the average trade being worth of $3,231. The most recent stock trade was executed by Daniel A. Camardo on 22 November 2022, trading 100,000 units of ATHX stock currently worth $55,000.
athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. we are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. this pipeline includes both stem cell therapy and pharmaceuticals.
Athersys Inc executives and other stock owners filed with the SEC include: